Preparing for Patient-Centric Drug Development Regulations

17:00 - 17:45

  • What do the recent FDA Guidelines on Patient-Focused Drug Development (PFDD) mean to us?
  • Why do we need more patient focussed thinking and design of drug products, medical devices and combination products?
  • How will become more patient focussed shake up the industry and make us more competitive

Zhengming Chen, Senior Director, Pharmaceutical Science , Shionogi

Diane Harper, Director Regulatory Affairs-CMC, Merck

Galen Shi, Senior Engineering Advisor, Eli Lilly